These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9094440)

  • 1. Neuroimmunomodulation in immune privilege: role of neuropeptides in ocular immunosuppression.
    Taylor AW
    Neuroimmunomodulation; 1996; 3(4):195-204. PubMed ID: 9094440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimmunomodulation and immune privilege: the role of neuropeptides in ocular immunosuppression.
    Taylor AW
    Neuroimmunomodulation; 2002-2003; 10(4):189-98. PubMed ID: 12584406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of antigen-stimulated effector T cells by human cerebrospinal fluid.
    Taylor AW; Streilein JW
    Neuroimmunomodulation; 1996; 3(2-3):112-8. PubMed ID: 8945726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural control of ocular immune privilege.
    Streilein JW; Okamoto S; Sano Y; Taylor AW
    Ann N Y Acad Sci; 2000; 917():297-306. PubMed ID: 11268357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular immunosuppressive microenvironment.
    Taylor AW
    Chem Immunol Allergy; 2007; 92():71-85. PubMed ID: 17264484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of nitric oxide generated by inflammatory macrophages by calcitonin gene-related peptide in aqueous humor.
    Taylor AW; Yee DG; Streilein JW
    Invest Ophthalmol Vis Sci; 1998 Jul; 39(8):1372-8. PubMed ID: 9660485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eye-derived cytokines and the immunosuppressive intraocular microenvironment: a review.
    Streilein JW; Wilbanks GA; Taylor A; Cousins S
    Curr Eye Res; 1992; 11 Suppl():41-7. PubMed ID: 1424750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation.
    Streilein JW
    J Leukoc Biol; 2003 Aug; 74(2):179-85. PubMed ID: 12885934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune privilege in the anterior chamber of the eye.
    Niederkorn JY
    Crit Rev Immunol; 2002; 22(1):13-46. PubMed ID: 12186187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical denervation of ocular sympathetic afferents decreases local transforming growth factor-beta and abolishes immune privilege.
    Vega JL; Keino H; Masli S
    Am J Pathol; 2009 Sep; 175(3):1218-25. PubMed ID: 19700755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular immune privilege and the impact of intraocular inflammation.
    Streilein JW; Ohta K; Mo JS; Taylor AW
    DNA Cell Biol; 2002; 21(5-6):453-9. PubMed ID: 12167248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular immune privilege sites.
    Masli S; Vega JL
    Methods Mol Biol; 2011; 677():449-58. PubMed ID: 20941626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye.
    Streilein JW
    Eye (Lond); 1995; 9 ( Pt 2)():236-40. PubMed ID: 7556724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular immune privilege in the immunosuppressive intraocular microenvironment.
    Streilein JW
    Ocul Immunol Inflamm; 1995; 3(2):139-44. PubMed ID: 22827281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the influence of aqueous humor on immunity.
    Taylor A
    Ocul Immunol Inflamm; 2003 Dec; 11(4):231-41. PubMed ID: 14704895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular immune privilege.
    Taylor AW
    Eye (Lond); 2009 Oct; 23(10):1885-9. PubMed ID: 19136922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor.
    Taylor AW; Streilein JW; Cousins SW
    J Immunol; 1994 Aug; 153(3):1080-6. PubMed ID: 8027541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of ocular immune responses.
    Streilein JW
    Eye (Lond); 1997; 11 ( Pt 2)():171-5. PubMed ID: 9349408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular immune privilege in the year 2010: ocular immune privilege and uveitis.
    Taylor AW; Kaplan HJ
    Ocul Immunol Inflamm; 2010 Dec; 18(6):488-92. PubMed ID: 21091058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local production of IFN-gamma abrogates the intraocular immune privilege in transgenic mice and prevents the induction of ACAID.
    Geiger K; Sarvetnick N
    J Immunol; 1994 Dec; 153(11):5239-46. PubMed ID: 7525729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.